Ohye H et al. |
Effects of immunosuppressant agents on growth hormone release and gene expression. |
1998 |
Endocr. J. |
pmid:9790238
|
Casavilla FA et al. |
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. |
1998 |
Liver Transpl Surg |
pmid:9791154
|
Toshima K et al. |
Effect of FK506 on the activation state of hepatic macrophages in Propionibacterium acnes-treated rats. |
1998 |
J. Gastroenterol. Hepatol. |
pmid:9792034
|
Sengoku T et al. |
[Effects of tacrolimus ointment on type I (immediate and late) and IV (delayed) cutaneous allergic reactions in mice]. |
1998 |
Nippon Yakurigaku Zasshi |
pmid:9793077
|
Hashimoto Y et al. |
Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats. |
1998 |
Pharm. Res. |
pmid:9794505
|
Kobayashi M et al. |
Effects of FK506 on experimental membranous glomerulonephritis induced by cationized bovine serum albumin in rats. |
1998 |
Nephrol. Dial. Transplant. |
pmid:9794552
|
Schaefer A et al. |
Stimulation of the Ca2+-mediated egr-1 and c-fos expression in murine erythroleukaemia cells by cyclosporin A. |
1998 |
Biochem. J. |
pmid:9794788
|
Whitcup SM et al. |
Topical liposome-encapsulated FK506 for the treatment of endotoxin-induced uveitis. |
1998 |
Ocul. Immunol. Inflamm. |
pmid:9798194
|
Sankary HN et al. |
FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. |
1998 |
Transplantation |
pmid:9798690
|
Garcia-Criado FJ et al. |
Possible tacrolimus action mechanisms in its protector effects on ischemia-reperfusion injury. |
1998 |
Transplantation |
pmid:9798713
|
Fisher NC |
Renal failure after lung transplantation. |
1998 |
Lancet |
pmid:9800782
|
Conti F et al. |
Low level of interleukin 10 synthesis during liver allograft rejection. |
1998 |
Lab. Invest. |
pmid:9800954
|
Reis A et al. |
A comparative investigation of FK506 and cyclosporin A in murine corneal transplantation. |
1998 |
Graefes Arch. Clin. Exp. Ophthalmol. |
pmid:9801895
|
Bieber T |
Topical tacrolimus (FK 506): a new milestone in the management of atopic dermatitis. |
1998 |
J. Allergy Clin. Immunol. |
pmid:9802361
|
Boguniewicz M et al. |
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. |
1998 |
J. Allergy Clin. Immunol. |
pmid:9802373
|
Faure JD et al. |
An Arabidopsis immunophilin, AtFKBP12, binds to AtFIP37 (FKBP interacting protein) in an interaction that is disrupted by FK506. |
1998 |
Plant J. |
pmid:9807817
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Hultsch T et al. |
Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner. |
1998 |
Arch. Dermatol. Res. |
pmid:9808344
|
Cacciarelli TV et al. |
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. |
1998 |
Transplantation |
pmid:9808490
|
Nakazawa Y et al. |
Relationship between in vivo FK506 clearance and in vitro 13-demethylation activity in living-related liver transplantation. |
1998 |
Transplantation |
pmid:9808496
|